
Real-world PFHO data show OSDI scores falling within 2 weeks, while a 12-month trial finds stable corneal endothelial cell density with cyclosporine 0.1%.
Purchase an AdaptDx Pro® dark adaptometer headset during AMD Awareness Month and enjoy no payments in February for the length of your subscription.* As a bonus, we'll send a press release to your local news outlets to create some buzz about your practice's commitment to AMD.
Ready for a new approach to AMD care?
Learn about this special offer before it expires!
Sponsored by:





